Results 201 to 210 of about 2,457,946 (249)

Species diversity and host plant associations of ambrosia beetles in Southeast Asian forests of Laos and Vietnam revealed by DNA barcoding

Insect Conservation and Diversity, EarlyView.
Integrative DNA barcoding of ambrosia beetles and host plants revealed 27 beetle species across 16 genera and extensive, previously undocumented host plant diversity in Laos and Vietnam. Host specificity varied widely among ambrosia beetles, with Xylosandrus crassiusculus emerging as a dominant generalist associated with 19 host species from 12 plant ...
Bounsanong Chouangthavy, Phongphayboun Phonepaseuth, Emiko Oguri, Shuichiro Tagane, Phetlasy Souladeth, Phonepadith Phewphanh, Dac Dai Nguyen, Anh D. Nguyen, Noriaki Murakami, Katsuyuki Eguchi, Takahiro Yoshida   +10 more
wiley   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Juan de Luque‐Fernández, Irene Rivera‐Ruiz, Irene Suárez‐Vergne, Inmaculada Sánchez‐Ramírez, Manuel Galán‐Gutiérrez, Antonio José Vélez García‐Nieto   +5 more
wiley   +1 more source

Multilingual Digital Search Behavior Reveals Cultural Disparities in Vitiligo Information Needs in Germany

International Journal of Dermatology, EarlyView.
Multilingual vitiligo‐related Google search queries in Germany (October 2019–May 2023) were extracted and thematically coded across German, English, Turkish, Arabic, Russian, and Polish. Relative patterns highlighted language‐specific emphases in treatment information, camouflage, depigmentation, psychosocial burden, and faith/home‐remedy terms ...
Lilian Rauch, Christine Gasteiger, Markus Böhm, Georg Pliszewski, Tilo Biedermann, Alexander Zink   +5 more
wiley   +1 more source

Disseminated Cryptococcosis under Fingolimod Therapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Sven C. Engler, Morna F. Schmidt, Ana Ortins‐Pina, David Kluwig, Amir S. Yazdi   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epidemiology of invasive fungal infection

International Journal of Antimicrobial Agents, 2008
Invasive fungal infection is a growing cause of morbidity and mortality in immunosuppressed patients. Furthermore, the use of azole prophylaxis against Candida species has coincided with an increase in the incidence of invasive aspergillosis and infections by other filamentous fungi such as Mucorales. New risk factors and different timescales for onset
Antonio Rivero
exaly   +3 more sources

Immunomodulation of invasive fungal infections

Infectious Disease Clinics of North America, 2003
Genetic and acquired (disease- or therapy- related) host immune factors increase the risk for IFIs. In addition to antifungal drug therapy, modulation of host defenses by the use of HGFs and IFN-gamma has been supported by extensive in vitro and in vivo preclinical data.
Emmanuel, Roilides, Caron A, Lyman, Paraskevi, Panagopoulou, Stephen, Chanock   +3 more
openaire   +2 more sources

Therapy of invasive fungal infections

The Netherlands Journal of Medicine, 1999
During the past decades, the incidence and severity of invasive fungal infections has been increasing. These events have lead to the development of new antifungal agents, and amphotericin B no longer is the standard therapy for a variety of invasive mycoses. Fluconazole has become the drug of choice for treatment of C.
Kullberg, B.J., Pauw, B.E. de
openaire   +3 more sources

Pathogenesis of invasive fungal infections

Current Opinion in Infectious Diseases, 2013
Invasive fungal infection (IFI) is increasingly being recognized as a significant cause of morbidity and mortality in immunosuppressed patients. This review focuses on the latest literature reports concerning the pathogenesis of IFI in this population.New virulence factors of Candida and Aspergillus have recently been identified.
Carolina, Garcia-Vidal, Diego, Viasus, Jordi, Carratalà   +2 more
openaire   +2 more sources

Immunodiagnosis of invasive fungal infection

Medical Mycology, 1992
Overview Invasive fungal infections are an important cause of morbidity and mortality, particularly in immunocompromised patients. The prognosis of these infections is poor unless they are diagnosed and treated promptly. Clinically, there is usually nothing specific to indicate a fungal infection and diagnosis depends on a combination of ...
Buckley, H R, Richardson, M D, Evans, E G, Wheat, L J   +3 more
openaire   +3 more sources

Glucocorticoids and invasive fungal infections

The Lancet, 2003
Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections.
Michail S, Lionakis, Dimitrios P, Kontoyiannis   +1 more
openaire   +2 more sources